Research peptide
Tirzepatide
Tirzepatide brings two incretin pathways together in a single molecule, activating both the GIP and the GLP-1 receptor. That dual-agonist character is exactly why laboratories reach for it when modelling multi-pathway metabolic signalling, receptor pharmacology and gut-brain crosstalk. Each vial is a lyophilised powder verified to ≥99% purity by HPLC, with a Certificate of Analysis on request. UK-based dispatch, strictly for preclinical and laboratory research. Research applications Dual GIP/GLP-1 receptor agonism and binding-kinetics assays Side-by-side studies against single-agonist GLP-1 peptides Insulin secretion and metabolic pathway modelling Appetite and gut-brain axis signalling research Pancreatic beta-cell function investigations Specifications Form: Lyophilised powder Purity: ≥99% (HPLC verified) Storage: −20°C, protected from light and moisture Available sizes: 10mg · 15mg · 20mg · 30mg · 40mg · 50mg · 60mg Certificate of Analysis: available on request
Size: 10mg
Multi-buy discount available
- Buy 2Save 5%
- Buy 3Save 10%
- Buy 5Save 15%
- Buy 10Save 20%
- 99%+ purity guaranteed
- COA available
- Same-day dispatch
- Secure checkout
Product details
- Tirzepatide receptor binding and agonism assays in controlled laboratory settings.
- In vitro pathway signalling studies requiring batch-documented research material.
- Analytical method development and HPLC reference characterisation.
- Institutional protocol workstreams that require published Certificates of Analysis.
